Cascara Ventures

Cascara Ventures operates as a venture capital firm, investing in early-stage biotech and healthcare companies across Europe. Its core strategy targets technology-driven solutions for prevention, therapy, and research within the life sciences sector. This encompasses innovative developments in vaccines, medical devices, and pharmaceuticals, ultimately advancing health domains.

Established in 2016 by Adriaan Hart de Ruijter, an experienced entrepreneur and investor in life sciences, his insight recognized significant potential in nascent technology-driven healthcare ventures. This inspired a dedicated fund to support their early stages. His pedigree guides Cascara’s strategic engagement with pioneering scientific developments.

Cascara Ventures primarily supports seed-stage founders and emerging companies, providing capital, active management, and strategic partnership. Its vision cultivates successful businesses by collaborating with outstanding entrepreneurs developing impactful health and life science solutions. The firm empowers innovators to bring transformative technologies to market, ultimately advancing healthcare.